

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 9.57994303 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 8.54963251 |
| 3 | cellular response to zinc ion (GO:0071294) | 7.46115039 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.97559859 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.64170834 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.21131550 |
| 7 | regulation of B cell differentiation (GO:0045577) | 6.16823169 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.92054839 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.92054839 |
| 10 | positive thymic T cell selection (GO:0045059) | 5.68640968 |
| 11 | mature B cell differentiation (GO:0002335) | 5.45250852 |
| 12 | B cell proliferation (GO:0042100) | 5.32781494 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.22800606 |
| 14 | positive regulation of B cell differentiation (GO:0045579) | 5.15138737 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.10992153 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.75420248 |
| 17 | regulation of B cell proliferation (GO:0030888) | 4.73421276 |
| 18 | cellular response to interleukin-15 (GO:0071350) | 4.72729791 |
| 19 | negative regulation of B cell proliferation (GO:0030889) | 4.72552395 |
| 20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.66752905 |
| 21 | response to interleukin-15 (GO:0070672) | 4.62550843 |
| 22 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.49753140 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.43452510 |
| 24 | T cell migration (GO:0072678) | 4.37734378 |
| 25 | regulation of B cell apoptotic process (GO:0002902) | 4.36498183 |
| 26 | thymic T cell selection (GO:0045061) | 4.28269117 |
| 27 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.22327708 |
| 28 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.21170068 |
| 29 | positive regulation of Rap GTPase activity (GO:0032854) | 4.17107746 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 4.14316221 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 4.14316221 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.14316221 |
| 33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.14316221 |
| 34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.14316221 |
| 35 | modulation by symbiont of host immune response (GO:0052553) | 4.14316221 |
| 36 | lymph node development (GO:0048535) | 4.13274855 |
| 37 | negative thymic T cell selection (GO:0045060) | 4.08763754 |
| 38 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.08201984 |
| 39 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.06086305 |
| 40 | positive T cell selection (GO:0043368) | 4.04569348 |
| 41 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.02881516 |
| 42 | detection of bacterium (GO:0016045) | 3.99973700 |
| 43 | mature B cell differentiation involved in immune response (GO:0002313) | 3.99274936 |
| 44 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.98969631 |
| 45 | defense response to protozoan (GO:0042832) | 3.98388161 |
| 46 | positive regulation of B cell proliferation (GO:0030890) | 3.97695824 |
| 47 | NIK/NF-kappaB signaling (GO:0038061) | 3.95029533 |
| 48 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.94331653 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.92789283 |
| 50 | T cell selection (GO:0045058) | 3.92207682 |
| 51 | negative regulation of B cell apoptotic process (GO:0002903) | 3.91737590 |
| 52 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.89564335 |
| 53 | B cell activation (GO:0042113) | 3.86443879 |
| 54 | detection of other organism (GO:0098543) | 3.83742951 |
| 55 | germinal center formation (GO:0002467) | 3.83452559 |
| 56 | B cell homeostasis (GO:0001782) | 3.82954469 |
| 57 | regulation of T cell tolerance induction (GO:0002664) | 3.78106264 |
| 58 | regulation of antigen processing and presentation (GO:0002577) | 3.76822774 |
| 59 | negative T cell selection (GO:0043383) | 3.75479965 |
| 60 | positive regulation of humoral immune response (GO:0002922) | 3.72017380 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.70290979 |
| 62 | type I interferon signaling pathway (GO:0060337) | 3.70290979 |
| 63 | negative regulation of T cell mediated immunity (GO:0002710) | 3.69205326 |
| 64 | negative regulation of histone methylation (GO:0031061) | 3.68302211 |
| 65 | response to type I interferon (GO:0034340) | 3.67916524 |
| 66 | negative regulation of phagocytosis (GO:0050765) | 3.66950172 |
| 67 | immunoglobulin mediated immune response (GO:0016064) | 3.64092582 |
| 68 | positive regulation of interferon-alpha production (GO:0032727) | 3.63887630 |
| 69 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.59765024 |
| 70 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.59765024 |
| 71 | regulation of regulatory T cell differentiation (GO:0045589) | 3.58188991 |
| 72 | lymphocyte homeostasis (GO:0002260) | 3.56549278 |
| 73 | T cell receptor signaling pathway (GO:0050852) | 3.55291049 |
| 74 | positive regulation of granulocyte differentiation (GO:0030854) | 3.54729457 |
| 75 | regulation of superoxide anion generation (GO:0032928) | 3.49880443 |
| 76 | regulation of interferon-alpha production (GO:0032647) | 3.48843970 |
| 77 | regulation of B cell activation (GO:0050864) | 3.47576299 |
| 78 | positive regulation of B cell activation (GO:0050871) | 3.47429208 |
| 79 | positive regulation of interleukin-2 production (GO:0032743) | 3.46924219 |
| 80 | B cell mediated immunity (GO:0019724) | 3.46780122 |
| 81 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.46736433 |
| 82 | regulation of Rap GTPase activity (GO:0032317) | 3.46680230 |
| 83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.44819698 |
| 84 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.44131388 |
| 85 | positive regulation of antigen processing and presentation (GO:0002579) | 3.43527692 |
| 86 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.41739646 |
| 87 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.41739646 |
| 88 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.41739646 |
| 89 | macrophage activation involved in immune response (GO:0002281) | 3.41445546 |
| 90 | T cell costimulation (GO:0031295) | 3.40325733 |
| 91 | positive regulation of immunoglobulin production (GO:0002639) | 3.40227007 |
| 92 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.36189661 |
| 93 | positive regulation of histone deacetylation (GO:0031065) | 3.35795586 |
| 94 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.35019910 |
| 95 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.33997000 |
| 96 | complement activation, classical pathway (GO:0006958) | 3.33663538 |
| 97 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.32976665 |
| 98 | respiratory burst (GO:0045730) | 3.32266625 |
| 99 | lymphocyte costimulation (GO:0031294) | 3.32196099 |
| 100 | response to protozoan (GO:0001562) | 3.32088291 |
| 101 | cytidine metabolic process (GO:0046087) | 3.29590871 |
| 102 | cytidine catabolic process (GO:0006216) | 3.29590871 |
| 103 | cytidine deamination (GO:0009972) | 3.29590871 |
| 104 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.27362940 |
| 105 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.26027908 |
| 106 | T cell homeostasis (GO:0043029) | 3.25179933 |
| 107 | regulation of tolerance induction (GO:0002643) | 3.23725420 |
| 108 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.23040761 |
| 109 | negative regulation of humoral immune response (GO:0002921) | 3.22807055 |
| 110 | mononuclear cell proliferation (GO:0032943) | 3.21487316 |
| 111 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.21439264 |
| 112 | lymphocyte proliferation (GO:0046651) | 3.21256259 |
| 113 | negative regulation of bone resorption (GO:0045779) | 3.16281492 |
| 114 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.15516570 |
| 115 | activated T cell proliferation (GO:0050798) | 3.15419852 |
| 116 | mast cell activation (GO:0045576) | 3.14681291 |
| 117 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.14407634 |
| 118 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.14209021 |
| 119 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.14209021 |
| 120 | neutrophil activation involved in immune response (GO:0002283) | 3.13715699 |
| 121 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.13550105 |
| 122 | interferon-gamma production (GO:0032609) | 3.12883489 |
| 123 | tolerance induction (GO:0002507) | 3.09771337 |
| 124 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.07658079 |
| 125 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06805909 |
| 126 | leukocyte homeostasis (GO:0001776) | 3.05302914 |
| 127 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.04370534 |
| 128 | regulation of cell killing (GO:0031341) | 3.02103518 |
| 129 | B cell differentiation (GO:0030183) | 3.00908996 |
| 130 | immune response-activating signal transduction (GO:0002757) | 2.99718290 |
| 131 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.99349580 |
| 132 | positive regulation of cell killing (GO:0031343) | 2.98099464 |
| 133 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.98050395 |
| 134 | regulation of alpha-beta T cell activation (GO:0046634) | 2.96989950 |
| 135 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.96764913 |
| 136 | humoral immune response (GO:0006959) | 2.95761211 |
| 137 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.94872888 |
| 138 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.94039614 |
| 139 | activation of JUN kinase activity (GO:0007257) | 2.93934758 |
| 140 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.93123498 |
| 141 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.92992549 |
| 142 | positive regulation of B cell mediated immunity (GO:0002714) | 2.92992549 |
| 143 | I-kappaB phosphorylation (GO:0007252) | 2.92593730 |
| 144 | neutrophil activation (GO:0042119) | 2.91834150 |
| 145 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.91542366 |
| 146 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.89282971 |
| 147 | positive regulation of interleukin-12 production (GO:0032735) | 2.87950641 |
| 148 | viral transcription (GO:0019083) | 2.86577904 |
| 149 | leukocyte proliferation (GO:0070661) | 2.86351982 |
| 150 | leukocyte aggregation (GO:0070486) | 2.85489308 |
| 151 | B cell activation involved in immune response (GO:0002312) | 2.84178563 |
| 152 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.83526015 |
| 153 | negative regulation of cell killing (GO:0031342) | 2.83526015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.23286362 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 5.15991638 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.10412855 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.63176782 |
| 5 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.18680436 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.85069509 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.52750266 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.50111873 |
| 9 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.22612871 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.11980944 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.01735590 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.97891484 |
| 13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.90561355 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.83373907 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.80599994 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.69167269 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.59079358 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.56816903 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.44413335 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.41096474 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.31216202 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21886314 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.20146953 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17905731 |
| 25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.17536816 |
| 26 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.15125298 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.14312134 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.10554420 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.10215420 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.04776638 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03504446 |
| 32 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.00956605 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.00219038 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.94967070 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.93373561 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.92609928 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.88588678 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.86409072 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84466946 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80766304 |
| 41 | MAF_26560356_Chip-Seq_TH2_Human | 1.80147799 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74949088 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66139889 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66113450 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.64964514 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56151911 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.54689682 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54321211 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53126594 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51139516 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48975507 |
| 52 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.48475369 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46354321 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45258182 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39566203 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38215440 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34340894 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34035792 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32138600 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24989438 |
| 61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23899984 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23470829 |
| 63 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.23273226 |
| 64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20910629 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20700528 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19273308 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13105922 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12183219 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11954390 |
| 70 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10166094 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09531014 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06837929 |
| 73 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.06236914 |
| 74 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03850931 |
| 75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00348755 |
| 76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00082575 |
| 77 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99984516 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99878747 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99063995 |
| 80 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98721134 |
| 81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96991634 |
| 82 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96810738 |
| 83 | P300_27268052_Chip-Seq_Bcells_Human | 0.95754424 |
| 84 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95385780 |
| 85 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.93572141 |
| 86 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92960310 |
| 87 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.92212988 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91357931 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90366214 |
| 90 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90086497 |
| 91 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.89529719 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89077595 |
| 93 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.88844822 |
| 94 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.88246517 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86655133 |
| 96 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.86145509 |
| 97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85074437 |
| 98 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84947513 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84825495 |
| 100 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83912284 |
| 101 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.83261131 |
| 102 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.83121545 |
| 103 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.82452948 |
| 104 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81670567 |
| 105 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.81412626 |
| 106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.79412998 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79247292 |
| 108 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79243153 |
| 109 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.79239118 |
| 110 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77603128 |
| 111 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75052635 |
| 112 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74449510 |
| 113 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.74354066 |
| 114 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70915436 |
| 115 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.69805378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.98156279 |
| 2 | MP0001790_abnormal_immune_system | 5.51067657 |
| 3 | MP0005387_immune_system_phenotype | 5.51067657 |
| 4 | MP0001800_abnormal_humoral_immune | 5.24424300 |
| 5 | MP0003303_peritoneal_inflammation | 3.97162974 |
| 6 | MP0002452_abnormal_antigen_presenting | 3.90662630 |
| 7 | MP0000685_abnormal_immune_system | 3.77622455 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.41922072 |
| 9 | MP0002723_abnormal_immune_serum | 3.23936419 |
| 10 | MP0002420_abnormal_adaptive_immunity | 3.16546507 |
| 11 | MP0003724_increased_susceptibility_to | 3.12953807 |
| 12 | MP0001819_abnormal_immune_cell | 3.05991335 |
| 13 | MP0005671_abnormal_response_to | 3.04751262 |
| 14 | MP0002398_abnormal_bone_marrow | 2.91360691 |
| 15 | MP0000716_abnormal_immune_system | 2.73272030 |
| 16 | MP0000689_abnormal_spleen_morphology | 2.63575924 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.46634566 |
| 18 | MP0004510_myositis | 2.42444095 |
| 19 | MP0002429_abnormal_blood_cell | 2.22062134 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.17429303 |
| 21 | MP0002722_abnormal_immune_system | 2.14829143 |
| 22 | MP0005025_abnormal_response_to | 2.09608741 |
| 23 | MP0001873_stomach_inflammation | 2.06994047 |
| 24 | MP0002419_abnormal_innate_immunity | 1.99110498 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.92508887 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.85028482 |
| 27 | MP0004381_abnormal_hair_follicle | 1.84758784 |
| 28 | MP0002405_respiratory_system_inflammati | 1.78754897 |
| 29 | MP0001853_heart_inflammation | 1.74830412 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.74575722 |
| 31 | MP0003436_decreased_susceptibility_to | 1.68331892 |
| 32 | MP0009785_altered_susceptibility_to | 1.66760940 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.63697474 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.58342980 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.57841001 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.55634781 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.45663456 |
| 38 | MP0005310_abnormal_salivary_gland | 1.45488374 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.41586079 |
| 40 | MP0004947_skin_inflammation | 1.38779443 |
| 41 | MP0002009_preneoplasia | 1.36330705 |
| 42 | MP0003866_abnormal_defecation | 1.35209854 |
| 43 | MP0002933_joint_inflammation | 1.32896120 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.32638615 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.32617736 |
| 46 | MP0008057_abnormal_DNA_replication | 1.26757557 |
| 47 | MP0001348_abnormal_lacrimal_gland | 1.24719476 |
| 48 | MP0010234_abnormal_vibrissa_follicle | 1.23637344 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.23358960 |
| 50 | MP0002006_tumorigenesis | 1.17559390 |
| 51 | MP0002136_abnormal_kidney_physiology | 1.08307932 |
| 52 | MP0003091_abnormal_cell_migration | 1.08301082 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.07307203 |
| 54 | MP0002132_abnormal_respiratory_system | 1.04615455 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.03884646 |
| 56 | MP0000858_altered_metastatic_potential | 1.02579700 |
| 57 | MP0001851_eye_inflammation | 1.01136467 |
| 58 | MP0008961_abnormal_basal_metabolism | 0.98633786 |
| 59 | MP0008469_abnormal_protein_level | 0.94043631 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 0.92837997 |
| 61 | MP0005174_abnormal_tail_pigmentation | 0.91676114 |
| 62 | MP0002019_abnormal_tumor_incidence | 0.91589199 |
| 63 | MP0001879_abnormal_lymphatic_vessel | 0.90536114 |
| 64 | MP0003045_fibrosis | 0.89613992 |
| 65 | MP0002998_abnormal_bone_remodeling | 0.88693814 |
| 66 | MP0003077_abnormal_cell_cycle | 0.81793581 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 0.78546095 |
| 68 | MP0000569_abnormal_digit_pigmentation | 0.77265440 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 0.76995010 |
| 70 | MP0003787_abnormal_imprinting | 0.75340986 |
| 71 | MP0008874_decreased_physiological_sensi | 0.73323707 |
| 72 | MP0004883_abnormal_blood_vessel | 0.73000052 |
| 73 | MP0002928_abnormal_bile_duct | 0.72539750 |
| 74 | MP0005076_abnormal_cell_differentiation | 0.68670155 |
| 75 | MP0000767_abnormal_smooth_muscle | 0.67890888 |
| 76 | MP0003566_abnormal_cell_adhesion | 0.66988698 |
| 77 | MP0006054_spinal_hemorrhage | 0.66498865 |
| 78 | MP0009763_increased_sensitivity_to | 0.65231374 |
| 79 | MP0002168_other_aberrant_phenotype | 0.64583766 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.63062920 |
| 81 | MP0001663_abnormal_digestive_system | 0.61234290 |
| 82 | MP0002163_abnormal_gland_morphology | 0.58867360 |
| 83 | MP0000490_abnormal_crypts_of | 0.58423020 |
| 84 | MP0000249_abnormal_blood_vessel | 0.58154651 |
| 85 | MP0005621_abnormal_cell_physiology | 0.57329859 |
| 86 | MP0008260_abnormal_autophagy | 0.56802719 |
| 87 | MP0000350_abnormal_cell_proliferation | 0.53727563 |
| 88 | MP0006082_CNS_inflammation | 0.53549896 |
| 89 | MP0005390_skeleton_phenotype | 0.53231988 |
| 90 | MP0005381_digestive/alimentary_phenotyp | 0.52391167 |
| 91 | MP0001545_abnormal_hematopoietic_system | 0.51269451 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.51269451 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.51046096 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.50412708 |
| 95 | MP0005645_abnormal_hypothalamus_physiol | 0.50172287 |
| 96 | MP0003690_abnormal_glial_cell | 0.48928575 |
| 97 | MP0005451_abnormal_body_composition | 0.48503075 |
| 98 | MP0001533_abnormal_skeleton_physiology | 0.48396402 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.47915224 |
| 100 | MP0003279_aneurysm | 0.47624378 |
| 101 | MP0003075_altered_response_to | 0.47072988 |
| 102 | MP0000609_abnormal_liver_physiology | 0.46624742 |
| 103 | MP0009278_abnormal_bone_marrow | 0.46398960 |
| 104 | MP0003453_abnormal_keratinocyte_physiol | 0.46109754 |
| 105 | MP0003795_abnormal_bone_structure | 0.46044709 |
| 106 | MP0000604_amyloidosis | 0.44680851 |
| 107 | MP0003172_abnormal_lysosome_physiology | 0.44582177 |
| 108 | MP0009840_abnormal_foam_cell | 0.44363394 |
| 109 | MP0005058_abnormal_lysosome_morphology | 0.44129322 |
| 110 | MP0003252_abnormal_bile_duct | 0.44100351 |
| 111 | MP0004130_abnormal_muscle_cell | 0.43654241 |
| 112 | MP0003828_pulmonary_edema | 0.42969781 |
| 113 | MP0005023_abnormal_wound_healing | 0.42488676 |
| 114 | MP0000733_abnormal_muscle_development | 0.41809305 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.41508913 |
| 116 | MP0005166_decreased_susceptibility_to | 0.40972392 |
| 117 | MP0009764_decreased_sensitivity_to | 0.40934414 |
| 118 | MP0000313_abnormal_cell_death | 0.40321131 |
| 119 | MP0009115_abnormal_fat_cell | 0.40246237 |
| 120 | MP0002135_abnormal_kidney_morphology | 0.40239248 |
| 121 | MP0002083_premature_death | 0.40172403 |
| 122 | MP0002254_reproductive_system_inflammat | 0.39964120 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.39625959 |
| 124 | MP0010094_abnormal_chromosome_stability | 0.39305159 |
| 125 | MP0001730_embryonic_growth_arrest | 0.38726868 |
| 126 | MP0001784_abnormal_fluid_regulation | 0.38389113 |
| 127 | MP0009643_abnormal_urine_homeostasis | 0.38336195 |
| 128 | MP0000371_diluted_coat_color | 0.37822586 |
| 129 | MP0000477_abnormal_intestine_morphology | 0.37527396 |
| 130 | MP0003448_altered_tumor_morphology | 0.37025552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.74883887 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 8.04765936 |
| 3 | Recurrent bronchitis (HP:0002837) | 6.94961611 |
| 4 | Colitis (HP:0002583) | 6.41327876 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.40814925 |
| 6 | Cellulitis (HP:0100658) | 6.10138597 |
| 7 | IgM deficiency (HP:0002850) | 5.58643139 |
| 8 | Papilloma (HP:0012740) | 5.50403404 |
| 9 | Verrucae (HP:0200043) | 5.50403404 |
| 10 | Inflammation of the large intestine (HP:0002037) | 5.44731605 |
| 11 | Gastrointestinal inflammation (HP:0004386) | 5.24557999 |
| 12 | Emphysema (HP:0002097) | 5.12180423 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.05581459 |
| 14 | Lymphopenia (HP:0001888) | 5.01784228 |
| 15 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.76704866 |
| 16 | Chronic sinusitis (HP:0011109) | 4.75839323 |
| 17 | Recurrent viral infections (HP:0004429) | 4.70258071 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 4.66193603 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.51242768 |
| 20 | Meningitis (HP:0001287) | 4.50514402 |
| 21 | Chronic otitis media (HP:0000389) | 4.38730904 |
| 22 | Abnormality of macrophages (HP:0004311) | 4.38581671 |
| 23 | Myositis (HP:0100614) | 4.28260807 |
| 24 | Stomatitis (HP:0010280) | 4.15430168 |
| 25 | Small epiphyses (HP:0010585) | 4.04642121 |
| 26 | Vasculitis (HP:0002633) | 4.02813273 |
| 27 | Bronchitis (HP:0012387) | 4.01872008 |
| 28 | Restrictive lung disease (HP:0002091) | 3.91206892 |
| 29 | Recurrent otitis media (HP:0000403) | 3.81616738 |
| 30 | IgA deficiency (HP:0002720) | 3.76402512 |
| 31 | Osteomyelitis (HP:0002754) | 3.68956788 |
| 32 | Recurrent lower respiratory tract infections (HP:0002783) | 3.68491389 |
| 33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.60349832 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.60349832 |
| 35 | Recurrent pneumonia (HP:0006532) | 3.59235606 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 3.58631857 |
| 37 | Optic neuritis (HP:0100653) | 3.58631857 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 3.58462341 |
| 39 | Mitral stenosis (HP:0001718) | 3.57260154 |
| 40 | Recurrent abscess formation (HP:0002722) | 3.56754067 |
| 41 | Orchitis (HP:0100796) | 3.52137337 |
| 42 | Recurrent bacterial skin infections (HP:0005406) | 3.48673844 |
| 43 | Recurrent fungal infections (HP:0002841) | 3.36236162 |
| 44 | Severe combined immunodeficiency (HP:0004430) | 3.32915931 |
| 45 | Viral hepatitis (HP:0006562) | 3.20110713 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 3.19561520 |
| 47 | Sepsis (HP:0100806) | 3.08242738 |
| 48 | Increased IgM level (HP:0003496) | 3.05540808 |
| 49 | Abnormality of the fingertips (HP:0001211) | 3.03034709 |
| 50 | Recurrent skin infections (HP:0001581) | 3.02513346 |
| 51 | Vertebral arch anomaly (HP:0008438) | 2.88012158 |
| 52 | Autoimmune hemolytic anemia (HP:0001890) | 2.87219698 |
| 53 | Urticaria (HP:0001025) | 2.84255735 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.79490161 |
| 55 | IgG deficiency (HP:0004315) | 2.77487939 |
| 56 | Granulocytopenia (HP:0001913) | 2.76977229 |
| 57 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.76083022 |
| 58 | Abnormality of B cell number (HP:0010975) | 2.75517149 |
| 59 | B lymphocytopenia (HP:0010976) | 2.75517149 |
| 60 | Leukocytosis (HP:0001974) | 2.75479466 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.72214647 |
| 62 | Combined immunodeficiency (HP:0005387) | 2.71907339 |
| 63 | Abnormality of T cells (HP:0002843) | 2.71824278 |
| 64 | Leukopenia (HP:0001882) | 2.70437314 |
| 65 | Nasal polyposis (HP:0100582) | 2.69409621 |
| 66 | Prolonged bleeding time (HP:0003010) | 2.64865210 |
| 67 | Chronic diarrhea (HP:0002028) | 2.64754479 |
| 68 | Thyroiditis (HP:0100646) | 2.63031478 |
| 69 | Flattened epiphyses (HP:0003071) | 2.62867374 |
| 70 | Lymphoma (HP:0002665) | 2.62120518 |
| 71 | Autoimmune thrombocytopenia (HP:0001973) | 2.57884250 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.57277984 |
| 73 | Interstitial pulmonary disease (HP:0006530) | 2.57034180 |
| 74 | Abnormality of eosinophils (HP:0001879) | 2.56357813 |
| 75 | Hemoptysis (HP:0002105) | 2.54079990 |
| 76 | Abnormality of the prostate (HP:0008775) | 2.51134099 |
| 77 | Eosinophilia (HP:0001880) | 2.49743678 |
| 78 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.46913815 |
| 79 | Gingivitis (HP:0000230) | 2.46459520 |
| 80 | Keratoconjunctivitis (HP:0001096) | 2.43791945 |
| 81 | T lymphocytopenia (HP:0005403) | 2.43431458 |
| 82 | Pustule (HP:0200039) | 2.43064027 |
| 83 | Hypergammaglobulinemia (HP:0010702) | 2.36882400 |
| 84 | Abnormality of T cell number (HP:0011839) | 2.36735237 |
| 85 | Encephalitis (HP:0002383) | 2.35865141 |
| 86 | Epistaxis (HP:0000421) | 2.34927138 |
| 87 | Thrombocytosis (HP:0001894) | 2.32114984 |
| 88 | Irregular vertebral endplates (HP:0003301) | 2.31607349 |
| 89 | Skin ulcer (HP:0200042) | 2.28417610 |
| 90 | Pulmonary embolism (HP:0002204) | 2.27996427 |
| 91 | Spontaneous hematomas (HP:0007420) | 2.26960842 |
| 92 | Skin rash (HP:0000988) | 2.25423241 |
| 93 | Pulmonary infiltrates (HP:0002113) | 2.25143844 |
| 94 | Abnormality of the pleura (HP:0002103) | 2.24747195 |
| 95 | Chronic obstructive pulmonary disease (HP:0006510) | 2.24414620 |
| 96 | Obstructive lung disease (HP:0006536) | 2.24414620 |
| 97 | Ulnar bowing (HP:0003031) | 2.23653231 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 2.23108473 |
| 99 | Increased IgE level (HP:0003212) | 2.21791406 |
| 100 | Hypoplasia of the thymus (HP:0000778) | 2.13028732 |
| 101 | Fatigue (HP:0012378) | 2.10128081 |
| 102 | Villous atrophy (HP:0011473) | 2.09755718 |
| 103 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.09755718 |
| 104 | Joint swelling (HP:0001386) | 2.09476107 |
| 105 | Gingival bleeding (HP:0000225) | 2.09140258 |
| 106 | Papilledema (HP:0001085) | 2.07850314 |
| 107 | Arthralgia (HP:0002829) | 2.04387014 |
| 108 | Hematochezia (HP:0002573) | 2.03476880 |
| 109 | Gangrene (HP:0100758) | 2.01278954 |
| 110 | Neutropenia (HP:0001875) | 2.01232013 |
| 111 | Xerostomia (HP:0000217) | 1.98056083 |
| 112 | Anorexia (HP:0002039) | 1.97338632 |
| 113 | Premature loss of primary teeth (HP:0006323) | 1.96837367 |
| 114 | Arthropathy (HP:0003040) | 1.96779699 |
| 115 | Arterial thrombosis (HP:0004420) | 1.95583073 |
| 116 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.94227524 |
| 117 | Absent epiphyses (HP:0010577) | 1.94227524 |
| 118 | Hepatitis (HP:0012115) | 1.93488253 |
| 119 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91145828 |
| 120 | Petechiae (HP:0000967) | 1.89883939 |
| 121 | Basal cell carcinoma (HP:0002671) | 1.86928272 |
| 122 | Acrocyanosis (HP:0001063) | 1.86669991 |
| 123 | Chest pain (HP:0100749) | 1.79679194 |
| 124 | Myocardial infarction (HP:0001658) | 1.76673044 |
| 125 | Abnormality of the vertebral endplates (HP:0005106) | 1.71265542 |
| 126 | Hypertensive crisis (HP:0100735) | 1.68299070 |
| 127 | Periodontitis (HP:0000704) | 1.67461987 |
| 128 | Abnormality of the intervertebral disk (HP:0005108) | 1.63397339 |
| 129 | Limited elbow extension (HP:0001377) | 1.62003011 |
| 130 | Resting tremor (HP:0002322) | 1.59050144 |
| 131 | Aortic regurgitation (HP:0001659) | 1.50985867 |
| 132 | Facial diplegia (HP:0001349) | 1.50891252 |
| 133 | Mucosal telangiectasiae (HP:0100579) | 1.49201143 |
| 134 | Barrel-shaped chest (HP:0001552) | 1.48454566 |
| 135 | Hypochromic anemia (HP:0001931) | 1.48377595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 7.66855709 |
| 2 | GRK6 | 3.94432181 |
| 3 | TXK | 3.63445168 |
| 4 | BLK | 3.15797843 |
| 5 | CSF1R | 2.96764097 |
| 6 | MAP3K10 | 2.89828606 |
| 7 | ERN1 | 2.88481621 |
| 8 | MAP3K13 | 2.79295735 |
| 9 | PRPF4B | 2.71478888 |
| 10 | SYK | 2.65462222 |
| 11 | LRRK2 | 2.64782163 |
| 12 | RIPK4 | 2.59139329 |
| 13 | STK10 | 2.52707616 |
| 14 | BTK | 2.41575195 |
| 15 | MAP3K14 | 2.27933011 |
| 16 | TESK2 | 2.23770471 |
| 17 | TYK2 | 1.93547835 |
| 18 | JAK1 | 1.89455984 |
| 19 | SIK2 | 1.84354916 |
| 20 | PASK | 1.80186476 |
| 21 | MST4 | 1.77754215 |
| 22 | CDK12 | 1.69951861 |
| 23 | GRK1 | 1.58639702 |
| 24 | LYN | 1.52701383 |
| 25 | IRAK3 | 1.46619362 |
| 26 | MARK3 | 1.39609554 |
| 27 | KIT | 1.38833108 |
| 28 | CSK | 1.38627175 |
| 29 | TAOK3 | 1.38357076 |
| 30 | HCK | 1.34719069 |
| 31 | IKBKB | 1.30449141 |
| 32 | SIK3 | 1.28943882 |
| 33 | TBK1 | 1.27938379 |
| 34 | TGFBR2 | 1.23088407 |
| 35 | JAK3 | 1.21633364 |
| 36 | MAP3K11 | 1.15642614 |
| 37 | ITK | 1.15555382 |
| 38 | BMPR2 | 1.15358999 |
| 39 | EIF2AK3 | 1.11181478 |
| 40 | EEF2K | 1.10548208 |
| 41 | IRAK4 | 1.09385015 |
| 42 | PRKCQ | 1.08712745 |
| 43 | CAMKK1 | 1.03780219 |
| 44 | ZAP70 | 1.03473247 |
| 45 | TEC | 1.01305099 |
| 46 | MAP3K9 | 0.98577045 |
| 47 | PRKCH | 0.97630396 |
| 48 | SIK1 | 0.97263031 |
| 49 | LCK | 0.96840649 |
| 50 | BRD4 | 0.96019454 |
| 51 | ALK | 0.95220848 |
| 52 | FES | 0.93898490 |
| 53 | CDC42BPA | 0.93859883 |
| 54 | TRIB3 | 0.91784848 |
| 55 | PIM1 | 0.91037454 |
| 56 | CLK1 | 0.87516787 |
| 57 | PRKD2 | 0.87391712 |
| 58 | KDR | 0.86417780 |
| 59 | MATK | 0.86301225 |
| 60 | TNK2 | 0.82996969 |
| 61 | RPS6KA4 | 0.81055502 |
| 62 | IKBKE | 0.80172484 |
| 63 | FGFR3 | 0.79270750 |
| 64 | CHUK | 0.78436526 |
| 65 | TAOK1 | 0.74822463 |
| 66 | FGFR4 | 0.73645500 |
| 67 | MAPK11 | 0.72726099 |
| 68 | MAP3K1 | 0.72156949 |
| 69 | MAP3K3 | 0.71058361 |
| 70 | HIPK2 | 0.68515136 |
| 71 | PDK1 | 0.66142358 |
| 72 | CAMKK2 | 0.65210192 |
| 73 | MAP2K2 | 0.63154000 |
| 74 | MAPK7 | 0.62612913 |
| 75 | SMG1 | 0.60979688 |
| 76 | MAPK12 | 0.56862346 |
| 77 | MAP2K3 | 0.56534136 |
| 78 | ABL1 | 0.56307008 |
| 79 | FGR | 0.53965599 |
| 80 | TAOK2 | 0.53167187 |
| 81 | CAMK1G | 0.52825754 |
| 82 | MAP3K7 | 0.52293321 |
| 83 | INSR | 0.51804893 |
| 84 | MELK | 0.51040401 |
| 85 | CDK4 | 0.50722206 |
| 86 | YES1 | 0.50328648 |
| 87 | CDK19 | 0.48462442 |
| 88 | PRKD1 | 0.46792689 |
| 89 | CAMK1D | 0.46365871 |
| 90 | FYN | 0.45984904 |
| 91 | CSNK1A1L | 0.44944526 |
| 92 | EPHB1 | 0.44324366 |
| 93 | KSR2 | 0.43844260 |
| 94 | PTK6 | 0.41438909 |
| 95 | PKN2 | 0.41304072 |
| 96 | CDK9 | 0.41192203 |
| 97 | WNK1 | 0.39613201 |
| 98 | IRAK1 | 0.38814148 |
| 99 | EGFR | 0.37226525 |
| 100 | SGK3 | 0.35783273 |
| 101 | MAPKAPK2 | 0.33664367 |
| 102 | PRKCD | 0.32718408 |
| 103 | JAK2 | 0.31318293 |
| 104 | NLK | 0.31274591 |
| 105 | TLK1 | 0.31252472 |
| 106 | NEK2 | 0.30830912 |
| 107 | MAP3K8 | 0.30601581 |
| 108 | CSNK1G1 | 0.30571976 |
| 109 | TTN | 0.28389910 |
| 110 | RPS6KC1 | 0.27929375 |
| 111 | RPS6KL1 | 0.27929375 |
| 112 | SCYL2 | 0.27217712 |
| 113 | PRKCI | 0.26712772 |
| 114 | STK24 | 0.25093131 |
| 115 | CSNK1G3 | 0.24678776 |
| 116 | EPHA3 | 0.24558556 |
| 117 | STK11 | 0.24217427 |
| 118 | GRK7 | 0.23763673 |
| 119 | RPS6KA6 | 0.23657565 |
| 120 | MARK2 | 0.23640320 |
| 121 | MAP3K5 | 0.23180661 |
| 122 | CDK6 | 0.21867586 |
| 123 | DYRK1B | 0.21860344 |
| 124 | IRAK2 | 0.21765369 |
| 125 | MAP2K1 | 0.21310184 |
| 126 | MAPK4 | 0.18644500 |
| 127 | PDPK1 | 0.18517498 |
| 128 | CSNK1D | 0.18306317 |
| 129 | MAPK3 | 0.15709766 |
| 130 | STK4 | 0.15524542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 6.66430878 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.33379698 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.67845640 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.66477537 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.16897794 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.08120424 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.85811439 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.72048249 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.40103825 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33739393 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.23183561 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.22307356 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.11400968 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95157557 |
| 15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.85008287 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.76383526 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.68345251 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.55726758 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48090151 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.45957512 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.45948949 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.40811390 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38146510 |
| 24 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.36512280 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.31469778 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.27089597 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26572624 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25158811 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.22073821 |
| 30 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.21717268 |
| 31 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.18927493 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.18031476 |
| 33 | Ribosome_Homo sapiens_hsa03010 | 1.17030412 |
| 34 | Platelet activation_Homo sapiens_hsa04611 | 1.16150035 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14939169 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13294947 |
| 37 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.12974248 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.10431304 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06027864 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.05691177 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04872861 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99058416 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97903584 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 0.96925493 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90976603 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88430715 |
| 47 | Mismatch repair_Homo sapiens_hsa03430 | 0.87273340 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85331895 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83863900 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83195110 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 0.83002427 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79370739 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78660869 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78377810 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75704404 |
| 56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75580543 |
| 57 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75217929 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74069845 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.72844690 |
| 60 | Malaria_Homo sapiens_hsa05144 | 0.72833509 |
| 61 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70280560 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65799071 |
| 63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63638773 |
| 64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.62319812 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60839469 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.60693291 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59846268 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.58789323 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.57749238 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57377202 |
| 71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57153463 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56396241 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54376037 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.54321653 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.53917990 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53878882 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52317114 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50890975 |
| 79 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48638557 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48352089 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47225457 |
| 82 | DNA replication_Homo sapiens_hsa03030 | 0.47132737 |
| 83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45850974 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45251091 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.44746210 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44282291 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44034925 |
| 88 | Spliceosome_Homo sapiens_hsa03040 | 0.43289199 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40558730 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.38730271 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38239254 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36294683 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36196125 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35924924 |
| 95 | Prostate cancer_Homo sapiens_hsa05215 | 0.35533658 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33764739 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33248959 |
| 98 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.32139297 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.31204846 |
| 100 | Allograft rejection_Homo sapiens_hsa05330 | 0.30241165 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29238662 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29174908 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27710519 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27414107 |
| 105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.25596043 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.25386050 |
| 107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23348029 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.23223637 |
| 109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.22767298 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22486104 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22257185 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.22208268 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.21700220 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21620944 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.21231303 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20760749 |
| 117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.20730650 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19928409 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.19415860 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17888560 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.12808779 |

